Neurologix (Neurologix) Treasury Stock : $0.00 Mil (As of Jun. 2011)

View and export this data going back to . Start your Free Trial

What is Neurologix Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Neurologix's treasury stock for the quarter that ended in Jun. 2011 was $0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Neurologix Treasury Stock Historical Data

The historical data trend for Neurologix's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurologix Treasury Stock Chart

Neurologix Annual Data

Trend

Dec01

Dec02

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Treasury Stock

Get a 7-Day Free Trial

Neurologix Quarterly Data
	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11
Treasury Stock	Get a 7-Day Free Trial															-	-	-	-	-

Neurologix Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Neurologix (Neurologix) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurologix Inc (GREY:NRGXQ) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

One Bridge Plaza, Fort Lee, NJ, USA, 07024

Website

http://www.neurologix.net

Neurologix Inc is a development stage company that is engaged in the research and development of proprietary treatments for disorders of the brain and central nervous system, using gene transfer and other innovative therapies.

Neurologix (Neurologix) Headlines

No Headlines